...
首页> 外文期刊>Journal of the European Academy of Dermatology and Venereology: JEADV >Augmented decision-making for acral lentiginous melanoma detection using deep convolutional neural networks
【24h】

Augmented decision-making for acral lentiginous melanoma detection using deep convolutional neural networks

机译:使用深度卷积神经网络进行增强的轴峰素黑色素瘤检测的决策

获取原文
获取原文并翻译 | 示例

摘要

Background Several studies have achieved high-level performance of melanoma detection using convolutional neural networks (CNNs). However, few have described the extent to which the implementation of CNNs improves the diagnostic performance of the physicians. Objective This study is aimed at developing a CNN for detecting acral lentiginous melanoma (ALM) and investigating whether its implementation can improve the initial decision for ALM detection made by the physicians. Methods A CNN was trained using 1072 dermoscopic images of acral benign nevi, ALM and intermediate tumours. To investigate whether the implementation of CNN can improve the initial decision for ALM detection, 60 physicians completed a three-stage survey. In Stage I, they were asked for their decisions solely on the basis of dermoscopic images provided to them. In Stage II, they were also provided with clinical information. In Stage III, they were provided with the additional diagnosis and probability predicted by the CNN. Results The accuracy of ALM detection in the participants was 74.7% (95% confidence interval [CI], 72.6-76.8%) in Stage I and 79.0% (95% CI, 76.7-81.2%) in Stage II. In Stage III, it was 86.9% (95% CI, 85.3-88.4%), which exceeds the accuracy delivered in Stage I by 12.2%p (95% CI, 10.1-14.3%p) and Stage II by 7.9%p (95% CI, 6.0-9.9%p). Moreover, the concordance between the participants considerably increased (Fleiss-kappa of 0.436 [95% CI, 0.437-0.573] in Stage I, 0.506 [95% CI, 0.621-0.749] in Stage II and 0.684 [95% CI, 0.621-0.749] in Stage III). Conclusions Augmented decision-making improved the performance of and concordance between the clinical decisions of a diverse group of experts. This study demonstrates the potential use of CNNs as an adjoining, decision-supporting system for physicians' decisions.
机译:背景技术使用卷积神经网络(CNNS)实现了Melanoma检测的高级别性能。然而,很少有少数描述了CNN的实施程度提高了医生的诊断表现。目的本研究旨在开发用于检测患有急性血管素黑色素瘤(ALM)的CNN,并调查其实施是否可以改善医生对ALM检测的初始决定。方法使用1072个贲门耳鼻喉癌症,ALM和中间肿瘤进行培训CNN。为了调查CNN的实施是否可以改善ALM检测的初始决定,60名医生完成了三阶段的调查。在舞台上,他们被要求基于提供给他们的Dermoscopic图像的基础上的决定。在II阶段,还提供临床信息。在第三阶段,它们提供了CNN预测的额外诊断和概率。结果,参与者中ALM检测的准确性为II期阶段I和79.0%(95%CI,76.7-81.2%)中的74.7%(95%置信区间[CI],72.6-76.8%)。 III阶段,其为86.9%(95%CI,85.3-88.4%),超过第I期阶段I的准确性12.2%P(95%CI,10.1-14.3%p)和阶段II,持续7.9%p( 95%CI,6.0-9.9%P)。此外,参与者之间的一致性显着增加(Fleiss-Kappa为0.436 [95%CI,0.437-0.573],II期中的0.506 [95%CI,0.621-0.749]和0.684 [95%CI,0.621- 0.749]在第三阶段)。结论增强决策改善了各种专家临床决策之间的表现和一致性。本研究表明CNNS作为医生决策的毗邻决策支持系统的潜在使用。

著录项

  • 来源
  • 作者单位

    Yonsei Univ Dept Dermatol Wonju Coll Med Wonju South Korea;

    Yonsei Univ Dept Biomed Engn Wonju South Korea;

    Yonsei Univ Dept Biomed Engn Wonju South Korea;

    Yonsei Univ Coll Med Severance Hosp Dept Dermatol &

    Cutaneous Biol Res Inst Seoul South Korea;

    Yonsei Univ Dept Dermatol Wonju Coll Med Wonju South Korea;

    Yonsei Univ Dept Prevent Med Wonju Coll Med Wonju South Korea;

    Yonsei Univ Coll Med Severance Hosp Dept Dermatol &

    Cutaneous Biol Res Inst Seoul South Korea;

    Stanford Univ Dept Radiat Oncol Stanford CA 94305 USA;

    Yonsei Univ Coll Med Severance Hosp Dept Dermatol &

    Cutaneous Biol Res Inst Seoul South Korea;

    Yonsei Univ Dept Biomed Engn Wonju South Korea;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 皮肤病学与性病学 ;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号